Sonnet BioTherapeutics Files 8-K
| Field | Detail |
|---|---|
| Company | Sonnet Biotherapeutics Holdings, Inc. |
| Form Type | 8-K |
| Filed Date | Mar 19, 2025 |
| Risk Level | low |
| Sentiment | neutral |
Sentiment: neutral
Topics: 8-K, disclosure, corporate-events
TL;DR
Sonnet BioTherapeutics filed an 8-K on 3/19/25, check for updates.
AI Summary
Sonnet BioTherapeutics Holdings, Inc. filed an 8-K on March 19, 2025, reporting on events including a Regulation FD Disclosure and Other Events. The filing also includes financial statements and exhibits. The company was formerly known as Chanticleer Holdings, Inc. and TULVINE SYSTEMS INC.
Why It Matters
This filing provides important updates and disclosures for Sonnet BioTherapeutics Holdings, Inc., which could impact investor understanding of the company's current status and future direction.
Risk Assessment
Risk Level: low — This is a routine filing of an 8-K, which typically reports on significant corporate events but doesn't inherently signal high risk.
Key Players & Entities
- Sonnet BioTherapeutics Holdings, Inc. (company) — Registrant
- Chanticleer Holdings, Inc. (company) — Former Company Name
- TULVINE SYSTEMS INC (company) — Former Company Name
- March 19, 2025 (date) — Date of Report
FAQ
What specific events are disclosed under Regulation FD and 'Other Events' in this 8-K filing?
The filing indicates disclosures related to Regulation FD and 'Other Events' but does not detail the specific nature of these events within the provided text.
When was Sonnet BioTherapeutics Holdings, Inc. formerly known as Chanticleer Holdings, Inc. and TULVINE SYSTEMS INC?
The filing states the date of name change from Chanticleer Holdings, Inc. was May 10, 2005, and from TULVINE SYSTEMS INC was February 14, 2000.
What is the principal executive office address for Sonnet BioTherapeutics Holdings, Inc.?
The principal executive office is located at 100 Overlook Center, Suite 102, Princeton, New Jersey 08540.
What is the Standard Industrial Classification (SIC) code for Sonnet BioTherapeutics Holdings, Inc.?
The SIC code listed is 2834, which corresponds to Pharmaceutical Preparations.
What is the fiscal year end for Sonnet BioTherapeutics Holdings, Inc.?
The fiscal year end for the company is September 30.
Filing Details
This Form 8-K (Form 8-K) was filed with the SEC on March 19, 2025 regarding Sonnet BioTherapeutics Holdings, Inc..